Review article: nutritional therapy in alcoholic liver disease

被引:94
作者
Stickel, F
Hoehn, B
Schuppan, D
Seitz, HK
机构
[1] Salem Med Ctr, Lab Alcohol Res Liver Dis & Nutr, D-69121 Heidelberg, Germany
[2] Univ Erlangen Nurnberg, Dept Med 1, D-8520 Erlangen, Germany
关键词
D O I
10.1046/j.1365-2036.2003.01660.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic alcohol consumption may lead to primary and secondary malnutrition. In particular, protein energy malnutrition not only aggravates alcoholic liver disease but also correlates with impaired liver function and increased mortality. Therefore, in these patients, adequate nutritional support should be implemented in order to improve their prognosis. Clinical trials addressing this issue have shown that nutritional therapy either enterally or parenterally improves various aspects of malnutrition, and there is increasing evidence that it may also improve survival. Therefore, malnourished alcoholics should be administered a diet rich in carbohydrate- and protein-derived calories preferentially via the oral or enteral route. Micronutrient deficiencies typically encountered in alcoholics, such as for thiamine and folate, require specific supplementation. Patients with hepatic encephalopathy may be treated with branched-chain amino acids in order to achieve a positive nitrogen balance. Fatty liver represents the early stage of alcoholic liver disease, which is usually reversible with abstinence. Metadoxine appears to improve fatty liver but confirmatory studies are necessary. S-adenosyl-L-methionine may be helpful for patients with severe alcoholic liver damage, since various mechanisms of alcohol-related hepatotoxicity are counteracted with this essential methyl group donor, while a recent large trial showed that the use of polyenylphosphatidylcholine is of limited efficacy.
引用
收藏
页码:357 / 373
页数:17
相关论文
共 103 条
[1]  
ACHORD JL, 1987, AM J GASTROENTEROL, V82, P871
[2]   Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma [J].
Avila, MA ;
Berasain, C ;
Torres, L ;
Martín-Duce, A ;
Corrales, FJ ;
Yang, HP ;
Prieto, J ;
Lu, SC ;
Caballería, J ;
Rodés, J ;
Mato, JM .
JOURNAL OF HEPATOLOGY, 2000, 33 (06) :907-914
[3]   S-Adenosylmethionine revisited:: its essential role in the regulation of liver function [J].
Avila, MA ;
García-Trevijano, ER ;
Martínez-Chantar, ML ;
Latasa, MU ;
Pérez-Mato, I ;
Martínez-Cruz, LA ;
del Pino, MMS ;
Corrales, FJ ;
Mato, JM .
ALCOHOL, 2002, 27 (03) :163-167
[4]   PROGNOSTIC-SIGNIFICANCE OF DIABETES IN PATIENTS WITH CIRRHOSIS [J].
BIANCHI, G ;
MARCHESINI, G ;
ZOLI, M ;
BUGIANESI, E ;
FABBRI, A ;
PISI, E .
HEPATOLOGY, 1994, 20 (01) :119-125
[5]  
BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1200
[6]  
BONKOVSKY HL, 1991, AM J GASTROENTEROL, V86, P1209
[7]  
BOVET P, 1998, J EPIDEMIOL COMMUNIT, V52, P148
[8]  
BUNOUT D, 1989, EUR J CLIN NUTR, V43, P615
[9]   Metadoxine accelerates fatty liver recovery in alcoholic patients:: results of a randomized double-blind, placebo-control trial [J].
Caballería, J ;
Parés, A ;
Brú, C ;
Mercader, J ;
Plaza, AG ;
Caballería, L ;
Clemente, G ;
Rodrigo, L ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 1998, 28 (01) :54-60
[10]   EFFECT OF TOTAL ENTERAL NUTRITION ON THE SHORT-TERM OUTCOME OF SEVERELY MALNOURISHED CIRRHOTICS - A RANDOMIZED CONTROLLED TRIAL [J].
CABRE, E ;
GONZALEZHUIX, F ;
ABADLACRUZ, A ;
ESTEVE, M ;
ACERO, D ;
FERNANDEZBANARES, F ;
XIOL, X ;
GASSULL, MA .
GASTROENTEROLOGY, 1990, 98 (03) :715-720